Dendritic cells (DCs) and alveolar macrophages phagocytose the virus-infected epithelial cells, followed by an immunosuppressive response characterized by lymphopenia, low CD4 and CD8 T cell counts and therefore an increased risk of bacterial infection [9], [10], [11]
Li, F., Huang, W., & Zhang, X
B12 deficiency also leads to anemia, causing these symptoms
While the use of rodents and small mammals is common for the development of novel therapeutic agents, it is recommended that caution should still be utilized when extrapolating available research to the clinical setting
Phase 3 TRIUMPH-4 trial The most recent Phase 3 results, announced in December 2025, tested retatrutide in people with obesity and knee osteoarthritis
In another rodent study, exenatide led to a marked reduction in cocaine-primed reinstatement without impacting sucrose-seeking behavior